Clinical Trial Update: Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating durvalumab in combination with stereotactic radiotherapy for advanced Non-Small Cell Lung Cancer; the study is currently not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Durvalumab (durvalumab)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING